Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An announcement from Opko Health ( (OPK) ) is now available.
OPKO Health announced it will report its financial results for the fourth quarter of 2024 on February 27, 2025. The announcement includes a conference call and webcast where senior management will provide a business update and discuss financial guidance, potentially impacting stakeholders by highlighting the company’s operational performance and future strategy.
More about Opko Health
OPKO Health is a multinational biopharmaceutical and diagnostics company focused on establishing leading positions in large, rapidly growing markets by utilizing its expertise in discovery, development, and commercialization, as well as novel and proprietary technologies.
YTD Price Performance: 13.10%
Average Trading Volume: 3,759,711
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $1.12B
See more data about OPK stock on TipRanks’ Stock Analysis page.
